opc 4392 and lisuride
opc 4392 has been researched along with lisuride in 2 studies
Compound Research Comparison
| Studies (opc 4392) | Trials (opc 4392) | Recent Studies (post-2010) (opc 4392) | Studies (lisuride) | Trials (lisuride) | Recent Studies (post-2010) (lisuride) |
|---|---|---|---|---|---|
| 16 | 1 | 0 | 756 | 80 | 31 |
Protein Interaction Comparison
| Protein | Taxonomy | opc 4392 (IC50) | lisuride (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.02 | |
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.041 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.559 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0003 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.016 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0029 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0005 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0043 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0005 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.173 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.04 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.041 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.003 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.02 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0005 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.16 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0002 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0051 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.012 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Burris, KD; Kikuchi, T; Miwa, T; Mori, T; Stark, A; Tadori, Y; Tottori, K | 1 |
| Chen, R; Johnson, JL; Jordan, S; Kambayashi, J; Kikuchi, T; Kitagawa, H; McQuade, R; Regardie, K; Tadori, Y | 1 |
Other Studies
2 other study(ies) available for opc 4392 and lisuride
| Article | Year |
|---|---|
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Lisuride; Piperazines; Piperidines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Risperidone; Transfection; Tritium | 2005 |
In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Calcium Signaling; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Immunoblotting; Lisuride; MAP Kinase Signaling System; Microscopy, Confocal; Mitogen-Activated Protein Kinase 1; Phosphorylation; Piperazines; Piperidines; Quinolones; Raclopride; Receptors, Dopamine D2; Schizophrenia; Time Factors; Transfection | 2007 |